Quick Answer
Crinetics Pharmaceuticals, Inc. reported Operating Income of -$516.77 million for fiscal year 2025.
Crinetics Pharmaceuticals, Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$516.77M | -52.5% |
| 2024 | -$338.85M | -52.2% |
| 2023 | -$222.61M | -32.6% |
| 2022 | -$167.88M | -55.9% |
| 2021 | -$107.70M | -43.7% |
| 2020 | -$74.95M | -39.2% |
| 2019 | -$53.83M | -87.5% |
| 2018 | -$28.71M | -214.6% |
| 2017 | -$9.13M | -51.0% |
| 2016 | -$6.04M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$142.59M | -62.4% | -10.4% |
| June 30, 2025 | -$129.11M | -56.0% | -15.9% |
| March 31, 2025 | -$111.41M | -51.5% | -26.9% |
| September 30, 2024 | -$87.80M | -48.9% | -6.1% |
| June 30, 2024 | -$82.78M | -56.2% | -12.6% |
| March 31, 2024 | -$73.53M | -53.3% | -24.7% |
| September 30, 2023 | -$58.98M | -35.7% | -11.3% |
| June 30, 2023 | -$52.99M | -23.1% | -10.5% |
- Crinetics Pharmaceuticals, Inc. showed a decrease of -52.5% in Operating Income compared to the prior fiscal year.
- Over the 2016–2025 period, Crinetics Pharmaceuticals, Inc.’s operating income has declined by 8450.1% (from -$6.04 million to -$516.77 million).
- The most recent figure is from Crinetics Pharmaceuticals, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: